Intravacc

Activities: Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Intravacc and Primrose Bio partner to enhance conjugate vaccine development

The expansion of the PeliCRM197 franchise creates a full-service solution for early-stage customers and partners
Drug Delivery

Intravaac shares publication of OMV-based intranasal vaccine review

The CDMO has shared the publication in Current Opinion in Immunology regarding the efficacy its OMV-based vaccines, administered intranasally
Drug Delivery

CEPI and Intravacc to develop Betacoronavirus vaccine

CEPI will provide seed funding of up to US$4.8 million to Intravacc - a world leader in translational research and development of preventive and therapeutic vaccines
Manufacturing

Intravacc awarded $14.6m toward gonorrhoea vaccine

Gonorrhoea is on the WHO high-priority list of antimicrobial resistant bacteria
Drug Delivery

Intravacc to begin clinical trials for nasal COVID vaccine

The design of the vaccine is aimed to provide broad protection, harnessing both arms of the immune system
Design & Build

Intravacc leads consortium on Dutch multi-purpose vaccine plant

It has also built a pilot production plant at Utrecht Science Park over the past 24 months
Finance

Intravacc and Cristal Therapeutics announce vaccine collaboration

As part of the agreement, Intravacc will provide access to its detoxified LPS technology to enhance immune activation
Subscribe now